Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Billiontoone Inc Cl A (BLLN)

Billiontoone Inc Cl A (BLLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,227,952
  • Shares Outstanding, K 45,966
  • Annual Sales, $ 305,110 K
  • Annual Income, $ 7,450 K
  • EBIT $ -3 M
  • EBITDA $ 28 M
  • 60-Month Beta N/A
  • Price/Sales 13.33
  • Price/Cash Flow 273.27
  • Price/Book 8.44

Options Overview Details

View History
  • Implied Volatility 93.50% (+3.21%)
  • Historical Volatility 87.36%
  • IV Percentile 79%
  • IV Rank 58.31%
  • IV High 105.24% on 02/27/26
  • IV Low 77.08% on 03/19/26
  • Expected Move (DTE 8) 11.43 (13.86%)
  • Put/Call Vol Ratio 0.12
  • Today's Volume 94
  • Volume Avg (30-Day) 133
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 1,129
  • Open Int (30-Day) 737
  • Expected Range 71.07 to 93.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.01
  • Number of Estimates 4
  • High Estimate $0.06
  • Low Estimate $-0.03
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.96 +33.15%
on 03/12/26
94.88 -13.05%
on 04/08/26
+10.39 (+14.41%)
since 03/09/26
3-Month
61.96 +33.15%
on 03/12/26
101.98 -19.10%
on 01/12/26
-3.44 (-4.00%)
since 01/09/26

Most Recent Stories

More News
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

Renowned physician executive and clinician-scientist joins BillionToOne to advance oncology medical strategy

BLLN : 82.50 (-10.31%)
BillionToOne: Q4 Earnings Snapshot

BillionToOne: Q4 Earnings Snapshot

BLLN : 82.50 (-10.31%)
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 82.50 (-10.31%)
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 82.50 (-10.31%)
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

Northstar PGx™ and Northstar Select CH™ extend clinical insight and utility of Northstar Select ® all from the same blood-draw

BLLN : 82.50 (-10.31%)
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

BLLN : 82.50 (-10.31%)
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Integration enables seamless ordering and results delivery within Epic for UNITY Complete® and Northstar® tests, creating a better patient and provider experience

BLLN : 82.50 (-10.31%)
BillionToOne Provides Guidance for 2026

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 82.50 (-10.31%)
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Ultra-sensitive liquid biopsy is expanding precision medicine access for patients in Japan with treatment-resistant non-small cell lung cancer (NSCLC)

BLLN : 82.50 (-10.31%)
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 82.50 (-10.31%)

Business Summary

BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.

See More

Key Turning Points

3rd Resistance Point 101.01
2nd Resistance Point 97.20
1st Resistance Point 89.85
Last Price 82.50
1st Support Level 78.69
2nd Support Level 74.88
3rd Support Level 67.53

See More

52-Week High 138.70
Fibonacci 61.8% 109.39
Fibonacci 50% 100.33
Fibonacci 38.2% 91.27
Last Price 82.50
52-Week Low 61.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.